Canopy Growth Corporation (T:WEED*CA)

Business Focus: Alternative Medicine

Sector:  Healthcare Industry:  Pharmaceuticals
See Regulatory Filings on SEDAR
Company Contact
Address: 1 Hershey Dr
Tel: N/A
IR: See website
Key People
John K. Bell
Independent Chairman of the Board
Mark Zekulin
President, Chief Executive Officer
Mike Lee
Acting Chief Financial Officer
Rade Nikola Kovacevic
Senior Vice President, Managing Director
Olivier Dufourmantelle
Senior Vice President - Strategic Expansion and Continuous Improvement
Mark Ware
Chief Medical Officer
Business Overview
Canopy Growth Corp, formerly Tweed Marijuana Inc, is a Canada-based multi-brand cannabis company. The Company, through its subsidiaries Tweed Inc, Bedrocan Canada Inc, Tweed Farms Inc and Mettrum Health Corp is engaged in the business of producing and selling legal marijuana in the Canadian medical market. It is also focusing on producing and selling marijuana in the recreational market in Canada. Its core brands are Tweed and Bedrocan. Tweed is a licensed producer of medical marijuana. Tweed's commercial license covers approximately 168,000 square feet of its Smiths Falls facility and allows Tweed to produce and sell approximately 3,540 kilograms of medical marijuana per year. Tweed's built-out production capacity is over 10 climate controlled indoor growing rooms. Bedrocan is a medical-grade cannabis. Bedrocan's over 52,000 square feet production facility in Toronto, Ontario is licensed, and includes over 30 vegetative and growing rooms, and over three dispensing rooms.
Financial Overview
For the fiscal year ended 31 March 2019, Canopy Growth Corp revenues increased from C$77.9M to C$226.3M. Net loss increased from C$70.4M to C$685.4M. Revenues reflect Canada segment increase from C$74.2M to C$198.5M, Outside of canada segment increase from C$3.7M to C$27.9M. Higher net loss reflects FV Adjustments of Financial Investments increase from C$0K to C$203.1M (expense).
Reporting Currency: Canadian Dollars
Enterprise value: $12,448M as of Mar 31, 2019
Annual revenue (TTM): $226.34M as of Mar 31, 2019
EBITDA (TTM): -$544.74M as of Mar 31, 2019
Net annual income (TTM): -$685.44M as of Mar 31, 2019
Free cash flow (TTM): -$1,203M as of Mar 31, 2019
Net Debt Last Fiscal Year: N/A
Shares outstanding: 345,786,461 as of Jul 4, 2019
TTM: Trailing Twelve Months
EBITDA: Earnings Before Interest, Taxes, Depreciation, & Amortization